Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,742,815
+$381,527 QoQ
Shares Held
49,246
+0.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#207
of 497 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $22,827,015 across 21 Biotechnology names. ROIV ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,887 | $2,678,471 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,938 | $2,452,852 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,691 | $2,301,486 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
5,658 | $1,788,437 | |
| 5 | ROIV |
Roivant Sciences Ltd.
This page
|
49,246 | $1,742,815 | |
| 6 | EXEL |
Exelixis, Inc.
|
30,229 | $1,644,759 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,398,754 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
4,647 | $1,324,255 |
All Filings in ROIV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,742,815 | 49,246 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,361,288 | 49,144 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $995,205 | 45,862 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $691,955 | 45,734 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $512,773 | 45,499 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $26,294 | 2,606 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $10,788 | 912 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,524 | 912 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $9,639 | 912 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,612 | 912 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,241 | 912 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,492 | 299 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,320 | 131 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $966 | 131 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,046 | 131 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||